AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
AbbVie Dividend Announcement
• AbbVie announced a quarterly dividend of $1.64 per ordinary share which will be made payable on 2025-02-14. Ex dividend date: 2025-01-15
• AbbVie's trailing twelve-month (TTM) dividend yield is 3.58%
• AbbVie's payout ratio for the trailing twelve months (TTM) is 212.79%
AbbVie Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2025-01-15 | $1.64 | quarterly | 2025-02-14 |
| 2024-10-15 | $1.55 | quarterly | 2024-11-15 |
| 2024-07-15 | $1.55 | quarterly | 2024-08-15 |
| 2024-04-12 | $1.55 | quarterly | 2024-05-15 |
| 2024-01-12 | $1.55 | quarterly | 2024-02-15 |
| 2023-10-12 | $1.48 | quarterly | 2023-11-15 |
| 2023-07-13 | $1.48 | quarterly | 2023-08-15 |
| 2023-04-13 | $1.48 | quarterly | 2023-05-15 |
| 2023-01-12 | $1.48 | quarterly | 2023-02-15 |
| 2022-10-13 | $1.41 | quarterly | 2022-11-15 |
| 2022-07-14 | $1.41 | quarterly | 2022-08-15 |
| 2022-04-13 | $1.41 | quarterly | 2022-05-16 |
| 2022-01-13 | $1.41 | quarterly | 2022-02-15 |
| 2021-10-14 | $1.30 | quarterly | 2021-11-15 |
| 2021-07-14 | $1.30 | quarterly | 2021-08-16 |
| 2021-04-14 | $1.30 | quarterly | 2021-05-14 |
| 2021-01-14 | $1.30 | quarterly | 2021-02-16 |
| 2020-10-14 | $1.18 | quarterly | 2020-11-16 |
| 2020-07-14 | $1.18 | quarterly | 2020-08-14 |
| 2020-04-14 | $1.18 | quarterly | 2020-05-15 |
| 2020-01-14 | $1.18 | quarterly | 2020-02-14 |
| 2019-10-11 | $1.07 | quarterly | 2019-11-15 |
| 2019-07-12 | $1.07 | quarterly | 2019-08-15 |
| 2019-04-12 | $1.07 | quarterly | 2019-05-15 |
| 2019-01-14 | $1.07 | quarterly | 2019-02-15 |
| 2018-10-12 | $0.96 | quarterly | 2018-11-15 |
| 2018-07-12 | $0.96 | quarterly | 2018-08-15 |
| 2018-04-12 | $0.96 | quarterly | 2018-05-15 |
| 2018-01-11 | $0.71 | quarterly | 2018-02-15 |
| 2017-10-12 | $0.64 | quarterly | 2017-11-15 |
| 2017-07-12 | $0.64 | quarterly | 2017-08-15 |
| 2017-04-11 | $0.64 | quarterly | 2017-05-15 |
| 2017-01-11 | $0.64 | quarterly | 2017-02-15 |
| 2016-10-12 | $0.57 | quarterly | 2016-11-15 |
| 2016-07-13 | $0.57 | quarterly | 2016-08-15 |
| 2016-04-13 | $0.57 | quarterly | 2016-05-16 |
| 2016-01-13 | $0.57 | quarterly | 2016-02-16 |
| 2015-10-13 | $0.51 | quarterly | 2015-11-16 |
| 2015-07-13 | $0.51 | quarterly | 2015-08-14 |
| 2015-04-13 | $0.51 | quarterly | 2015-05-15 |
| 2015-01-13 | $0.49 | quarterly | 2015-02-13 |
| 2014-10-10 | $0.42 | quarterly | 2014-11-17 |
| 2014-07-11 | $0.42 | quarterly | 2014-08-15 |
| 2014-04-11 | $0.42 | quarterly | 2014-05-15 |
| 2014-01-13 | $0.40 | quarterly | 2014-02-14 |
AbbVie Dividend per year
AbbVie Dividend growth
AbbVie Dividend Yield
AbbVie current trailing twelve-month (TTM) dividend yield is 3.58%. Interested in purchasing AbbVie stock? Use our calculator to estimate your expected dividend yield:
AbbVie Financial Ratios
P/E ratio59.88
PEG ratio0.71
P/B ratio50.84
ROE65.72%
Payout ratio212.79%
Current ratio0.65
Quick ratio0.54
Cash Ratio0.17
AbbVie Dividend FAQ
How much is the next AbbVie dividend?
AbbVie's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next AbbVie dividend. The next AbbVie dividend will be released in January, April, July, or October.
When is AbbVie dividend paid?
AbbVie pays dividends on a quarterly basis. The specific dates may vary each year but are generally around January, April, July, and October. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does AbbVie pay?
The specific amount of AbbVie dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find AbbVie's dividend history.
Does AbbVie stock pay dividends?
Yes, AbbVie does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find AbbVie's dividend history.
How much dividend does AbbVie pay?
AbbVie paid $6.2 in 2024, $5.92 in 2023, $5.64 in 2022, $5.2 in 2021, and $4.72 in 2020.
How often does AbbVie pay dividends?
AbbVie typically pays dividends on a quarterly basis. This means that dividends are usually distributed 4 times a year. The specific payout dates may vary each year but generally fall around January, April, July, and October.
What is AbbVie's dividend yield?
The current dividend yield for AbbVie is 3.58%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate AbbVie's exact dividend yield.
When does AbbVie go ex dividend?
AbbVie's ex-dividend date for the latest dividend was on 2025-01-15. AbbVie typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next AbbVie dividend paid?
AbbVie pays dividends on a quarterly basis, typically around January, April, July, or October, but the exact dates can vary each year.
Will AbbVie increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether AbbVie will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is AbbVie dividend per share?
AbbVie paid $6.2 per share in 2024 and $5.92 per share in 2023. The amount of dividend per share that AbbVie pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is AbbVie a dividend aristocrat?
Yes, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AbbVie a dividend king?
Yes, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AbbVie a dividend stock?
Yes, AbbVie is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is AbbVie a good dividend stock?
Whether AbbVie is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. AbbVie has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating AbbVie as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Other factors to consider when evaluating AbbVie as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does AbbVie pay dividends monthly?
AbbVie typically pays dividends on a quarterly basis.
Does AbbVie pay dividends quarterly?
AbbVie currently pays dividends on a quarterly basis.
Has AbbVie ever paid a dividend?
Yes, AbbVie has a history of paying dividends to its shareholders. AbbVie is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy AbbVie dividend stocks?
To buy AbbVie you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy AbbVie stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy AbbVie stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does AbbVie pay dividends 2024?
AbbVie pays dividends on a quarterly basis. 2024 dividend payments are in 2025-02-14. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will AbbVie increase its dividend in 2024?
Decisions regarding AbbVie dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date AbbVie dividend overview you can look into the above table of dividend history.
How AbbVie dividend works?
The AbbVie dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how AbbVie's dividend process works:
1. Determination of Dividend: AbbVie's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, AbbVie publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, AbbVie distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from AbbVie are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Determination of Dividend: AbbVie's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, AbbVie publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, AbbVie distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from AbbVie are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are AbbVie dividends paid?
AbbVie dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: AbbVie sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, AbbVie distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: AbbVie declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
1. Record Date: AbbVie sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, AbbVie distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: AbbVie declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does AbbVie pay dividends?
AbbVie typically pays dividends on a quarterly basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does AbbVie pay dividends?
The general pattern is that AbbVie pays dividends around January, April, July, and October. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is AbbVie dividend safe?
The safety of AbbVie's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of AbbVie's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review AbbVie's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.
To assess the safety of AbbVie's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review AbbVie's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.